Modulus Discovery, Inc., an early stage global biopharmaceutical company with offices in Tokyo, Japan and Cambridge, MA, announced today the appointment of Taisuke Takahashi, Ph.D., as Vice President and Head of Chemistry.

Dr. Takahashi joins us from Astellas Pharma where he worked for 13 years in R&D as a medicinal chemist. During his tenure, he spent nearly two and a half years as Visiting Scientist and liason to Astellas Pharma at Mitobridge in Cambridge, MA, where he led multiple drug discovery programs with extensive use of global CROs. He has contributed to the delivery of multiple IND compounds which in part led to the recent $450M acquisition of the company by Astellas.

At Modulus, Dr. Takahashi will work closely with our CSO and computational platform team to lead all aspects of our medicinal chemistry research. Taisuke holds a Ph.D. from Tohoku University.

Comment from S. Roy Kimura, CEO of Modulus Discovery, Inc.
“We are very pleased to welcome Dr. Taisuke Takahashi to our team as Head of Medicinal Chemistry at Modulus Discovery. Dr. Takahashi brings with him the depth and breadth of medicinal chemistry and drug design experience that perfectly complements our computational discovery team. We are looking forward to driving and accelerating our drug design efforts under his chemistry leadership.”

Comment from Taisuke Takahashi, VP, Head of Chemistry of Modulus Discovery, Inc.
“I am very excited to join in Modulus Discovery, who drives small molecule drug discovery strongly by leveraging state-of-the-art computational science platform. I will make my best efforts to push Modulus’ discovery programs forward to find the groundbreaking drugs, utilizing my experiences both at Japanese pharma and US biotech.”